Measles and Rubella monitoring, June 2013
Measles and rubella are targeted for elimination in Europe by 2015. ECDC closely monitors progress towards interruption of endemic transmission of both diseases through enhanced surveillance and epidemic intelligence. Measles and rubella vaccinations are routinely delivered as trivalent measles-mumps-rubella (MMR) vaccine in Europe, and the first of the two recommended doses is normally given during the second year of life.
HIV/AIDS surveillance in Europe 2021 (2020 data)
30 Nov 2021 - This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been summarizing data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007.
Influenza virus characterisation - Summary Europe, October 2021
16 Nov 2021 - This is the first report for the 2021-2022 influenza season. As of week 44/2021, only 965 influenza detections across the WHO European Region were reported to TESSy.
Gonococcal antimicrobial susceptibility surveillance in the European Union/European Economic Area, 2019
15 Nov 2021 - The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) is essential for detecting emerging and increasing antimicrobial resistance. Since 2009, this surveillance has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC). The quality-assured data produced can be used to inform treatment guidelines.